CDX2 and neoplasm: Surgical resection remains the primary treatment for stage I to III tumors, with prognosis influenced by various pathologic, clinical, molecular, and histologic factors, such as histologic grade, tumor–node–metastasis staging, preoperative carcinoembryonic antigen levels, mismatch repair deficiency status, and presence of CDX2 (26–32).